Healthcare provider profile · identity verified

Thomas J Avella, M.D.

Internal Medicine · STONY POINT, NY · NPI 1932105541

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	639	191
Amlodipine Besylate	Amlodipine Besylate	477	156
Pantoprazole Sodium	Pantoprazole Sodium	299	99
Rosuvastatin Calcium	Rosuvastatin Calcium	275	92
Levothyroxine Sodium	Levothyroxine Sodium	246	72
Metformin Hcl Er	Metformin Hcl	234	77
Alprazolam	Alprazolam	228	51
Omeprazole	Omeprazole	190	58
Metoprolol Succinate	Metoprolol Succinate	189	59
Olmesartan Medoxomil	Olmesartan Medoxomil	188	60
Simvastatin	Simvastatin	184	58
Valsartan	Valsartan	167	46
Losartan Potassium	Losartan Potassium	164	59
Metformin Hcl	Metformin Hcl	141	42
Gabapentin	Gabapentin	137	39
Lisinopril	Lisinopril	132	41
Allopurinol	Allopurinol	129	36
Tamsulosin Hcl	Tamsulosin Hcl	127	41
Sertraline Hcl	Sertraline Hcl	124	35
Furosemide	Furosemide	97	44
Trazodone Hcl	Trazodone Hcl	94	31
Hydrochlorothiazide	Hydrochlorothiazide	92	27
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	90	21
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	90	27
Mounjaro	Tirzepatide	89	12
Fluticasone Propionate	Fluticasone Propionate	86	31
Ozempic	Semaglutide	86	20
Albuterol Sulfate Hfa	Albuterol Sulfate	80	27
Zolpidem Tartrate	Zolpidem Tartrate	80	16
Famotidine	Famotidine	78	25
Jardiance	Empagliflozin	74	21
Chlorthalidone	Chlorthalidone	67	25
Escitalopram Oxalate	Escitalopram Oxalate	67	23
Finasteride	Finasteride	66	22
Meloxicam	Meloxicam	66	33
Methylprednisolone	Methylprednisolone	64	58
Triamcinolone Acetonide	Triamcinolone Acetonide	63	40
Carvedilol	Carvedilol	60	18
Metoprolol Tartrate	Metoprolol Tartrate	59	22
Quetiapine Fumarate	Quetiapine Fumarate	58	13
Glimepiride	Glimepiride	57	13
Duloxetine Hcl	Duloxetine Hcl	56	17
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	56	17
Montelukast Sodium	Montelukast Sodium	54	23
Paroxetine Hcl	Paroxetine Hcl	53	13
Potassium Chloride	Potassium Chloride	53	20
Ezetimibe	Ezetimibe	51	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	15
Pravastatin Sodium	Pravastatin Sodium	49	17
Clonazepam	Clonazepam	46	11
Celecoxib	Celecoxib	45	suppressed
Benazepril Hcl	Benazepril Hcl	42	11
Tramadol Hcl	Tramadol Hcl	42	suppressed
Trulicity	Dulaglutide	41	11
Hydralazine Hcl	Hydralazine Hcl	40	12
Atenolol	Atenolol	39	11
Clotrimazole	Clotrimazole	38	21
Donepezil Hcl	Donepezil Hcl	37	suppressed
Mirtazapine	Mirtazapine	34	11
Pioglitazone Hcl	Pioglitazone Hcl	34	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	11
Doxycycline Hyclate	Doxycycline Hyclate	33	29
Doxazosin Mesylate	Doxazosin Mesylate	32	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	31	12
Azithromycin	Azithromycin	31	29
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	30	suppressed
Prednisone	Prednisone	30	19
Synthroid	Levothyroxine Sodium	30	suppressed
Eliquis	Apixaban	27	suppressed
Oxycodone Hcl	Oxycodone Hcl	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Spironolactone	Spironolactone	25	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	21
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	21	suppressed
Ammonium Lactate	Ammonium Lactate	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Ibandronate Sodium	Ibandronate Sodium	21	suppressed
Labetalol Hcl	Labetalol Hcl	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Ramipril	Ramipril	21	suppressed
Tradjenta	Linagliptin	21	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	20	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Eszopiclone	Eszopiclone	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Mupirocin	Mupirocin	19	13
Nystatin	Nystatin	19	suppressed
Irbesartan	Irbesartan	18	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	18	suppressed
Memantine Hcl Er	Memantine Hcl	18	suppressed
Nebivolol Hcl	Nebivolol Hcl	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Diazepam	Diazepam	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Baclofen	Baclofen	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Cefdinir	Cefdinir	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Primidone	Primidone	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error